title: Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity.
authors.affiliation: Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.
authors.forename: P
authors.initials: P
authors.lastname: Endara
authors.forename: M
authors.initials: M
authors.lastname: Vaca
authors.forename: M E
authors.initials: ME
authors.lastname: Chico
authors.forename: S
authors.initials: S
authors.lastname: Erazo
authors.forename: G
authors.initials: G
authors.lastname: Oviedo
authors.forename: I
authors.initials: I
authors.lastname: Quinzo
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez
authors.forename: R
authors.initials: R
authors.lastname: Lovato
authors.forename: A-L
authors.initials: AL
authors.lastname: Moncayo
authors.forename: M L
authors.initials: ML
authors.lastname: Barreto
authors.forename: L C
authors.initials: LC
authors.lastname: Rodrigues
authors.forename: P J
authors.initials: PJ
authors.lastname: Cooper
mesh_terms: D000293:Adolescent; D000871:Anthelmintics / Q000008:administration & dosage* / Q000009:adverse effects; D001250:Asthma, Exercise-Induced / Q000453:epidemiology; D002648:Child; D003233:Conjunctivitis, Allergic / Q000453:epidemiology; D004334:Drug Administration Schedule; D004484:Ecuador / Q000453:epidemiology; D004485:Eczema / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology; D007559:Ivermectin / Q000008:administration & dosage* / Q000009:adverse effects; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D009855:Onchocerciasis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D015995:Prevalence; D012220:Rhinitis / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors; D012424:Rural Population; D012882:Skin Tests; D013997:Time Factors
chemical_list: D000871:Anthelmintics; D007559:Ivermectin